Immunosuppression underlies resistance to anti-angiogenic therapy
Friday, July 14, 2017 - 14:02
in Health & Medicine
A novel mechanism behind resistance to angiogenesis inhibitors has now been identified -- drugs that fight cancer by suppressing the formation of new blood vessels.